Go back
HSA-MIR-34A
| Id | 53 |
| Name | hsa-mir-34a |
| Chromosome | chr1 (NC_000001) |
| PrecStart | 9151668 |
| PrecEnd | 9151777 |
| Length | 110 |
| Strand | reverse |
| Is at most 5 Mbp to chromosome end | Yes |
| Is at most 5 Mbp to chromosome centromere | Yes |
| Protein host gene | No |
| Intronic | No |
| Clustered | No |
| Probability | 0.48700575776292687 |
| ChrEnd | 1 |
| ChrCentr | 1 |
DOI | Detected in | In presence of | Expression profile |
|---|---|---|---|
| https://doi.org/10.1308/rcsann.2007.89.3.329a | McGurk Mark (2007). Squamous Cell Head and Neck Cancer. The Annals of The Royal College of Surgeons of England, 89(3), 329-329. | oropharyngeal cancer | up |
| https://doi.org/10.1016/j.jhep.2016.02.024 | Han Yuyan, Meng Fanyin, Venter Julie, Wu Nan, Wan Ying, Standeford Holly, Francis Heather, Meininger Cynthia, Greene John, Trzeciakowski Jerome P., Ehrlich Laurent, Glaser Shannon, Alpini Gianfranco (2016). miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth. Journal of Hepatology, 64(6), 1295-1304. | cholangiocarcinoma | up |
| https://doi.org/10.14218/jcth.2016.00031 | (2016). miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology, 4(4), 300-305. | hepatocellular carcinoma | up |
| https://doi.org/10.1007/174_2013_934 | Nieder Carsten (2013). Head and Neck Squamous Cell Cancer. Medical Radiology, (), 61-75. | laryngeal cancer | up |
| https://doi.org/10.1016/j.humpath.2018.05.019 | Shabani Noushin, Razaviyan Javad, Paryan Mahdi, Tavangar Seyed Mohammad, Azizi Fereidoun, Mohammadi-Yeganeh Samira, Hedayati Mehdi (2018). Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC. Human Pathology, 79(), 212-221. | medullary thyroid carcinoma | up |
| https://doi.org/10.1002/jcp.24422 | Franchina Tindara, Amodeo Valeria, Bronte Giuseppe, Savio Giuseppina, Ricciardi Giuseppina RR, Picciotto Maria, Russo Antonio, Giordano Antonio, Adamo Vincenzo (2013). Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. Journal of Cellular Physiology, (), n/a-n/a. | non-small cell lung cancer | up |
| https://doi.org/10.1186/s13000-015-0272-6 | Vychytilova-Faltejskova Petra, Kiss Igor, Klusova Sona, Hlavsa Jan, Prochazka Vladimir, Kala Zdenek, Mazanec Jan, Hausnerova Jitka, Kren Leos, Hermanova Marketa, Lenz Jiri, Karasek Petr, Vyzula Rostislav, Slaby Ondrej (2015). MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. Diagnostic Pathology, 10(1), . | pancreatic ductal adenocarcinoma | up |
| https://doi.org/10.1016/j.bbrc.2013.11.010 | Ma Yanfei, Qin Huadong, Cui Yunfu (2013). MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Biochemical and Biophysical Research Communications, 441(4), 958-963. | papillary thyroid carcinoma | up |
| https://doi.org/10.1016/s0959-8049(12)71744-6 | Gocze K., Kovacs K., Kajtar B., Benczik M., Gocze P., Ember I. (2012). 1148 Comparative MicroRNA Expression Profiles in Human Cervical Cancer. European Journal of Cancer, 48(), S276. | squamous carcinoma | up |
| https://doi.org/10.1016/j.jhep.2016.02.024 | Han Yuyan, Meng Fanyin, Venter Julie, Wu Nan, Wan Ying, Standeford Holly, Francis Heather, Meininger Cynthia, Greene John, Trzeciakowski Jerome P., Ehrlich Laurent, Glaser Shannon, Alpini Gianfranco (2016). miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth. Journal of Hepatology, 64(6), 1295-1304. | cholangiocarciFalsema | up |